Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 2004

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Male hormonal contraception.

AUTHORS

Wang C; Swerdloff RS

SOURCE

American Journal of Obstetrics and Gynecology. 2004 Apr;190(4 Suppl 1):S60-S68.

ABSTRACT

Male hormonal contraception, based on the suppression of both gonadotropins, follicle-stimulating hormone and

luteinizing hormone, resulting in marked decrease in sperm production, is designed for couples in stable

relationships where the male partner desires to assume family planning responsibilities using reversible methods.

Two large scale, multicenter studies that used testosterone injections as the prototype male hormonal contraceptive

demonstrated when azoospermia and/or very severe oligozoospermia were attained, contraceptive efficacy was

equivalent to female hormonal methods. Current studies aim to find the androgen alone or androgen plus progestin

preparations that are most efficacious, user friendly, and with least potential adverse effects. It is likely that

injections or implants of androgens either alone or with progestins will become the first male hormonal contraceptive

available within this decade. Further research and development include the use of selective androgen and/or

progestin receptor modulators, nonpeptide GnRH antagonists, and agents with local actions on the testis for male

contraception. (PubHealth.info Document ID: CONT1T 581-06)

PubHealth.info NOTE: The author(s) of this article titled, "Male hormonal contraception.", is(are) Wang C; Swerdloff

RS. The source of this article is "American Journal of Obstetrics and Gynecology. 2004 Apr;190(4 Suppl 1):S60-

S68.". This article was published in 2004 in English language(s). (PubHealth.info® Document ID: CONT1T 581-06.

All rights reserved with PubHealth.info) PIN: 581

This article is peer-reviewed.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.